The clinical course of cocaine abuse has been characterized as progressing through a number of temporal stages that advance from initial experimentation through casual use and finally to addiction. On a neurobiological level, this clinical course is paralleled by changes in the response to cocaine with repeated exposure, as well as residual changes in brain function and structure that may persist despite prolonged periods of abstinence from drug use. The studies proposed in the present application will focus on the neuroadaptations that accompany long term exposure to cocaine. We will focus on animals self-administration models, as these models provide valid predictions of human cocaine abuse. Furthermore, differences in the behavioral, pharmacological, and neurochemical responses to cocaine have been shown between self- administered cocaine and cocaine administered non-contingently. In preliminary studies we have observed progressive changes in the patterns of functional activity with continued experience with cocaine self- administration. Structure that form part of the neuroanatomical circuit mediate cocaine self-administration in its initial stages are different from those that appear to be involved later in course of experience with self-administration. Such neuroadaptations may underlie the overall progression of self-administration as it eventually leads to addiction. The overall goals of this project, then are, (1) to extend these findings to examine more closely the evolution of the functional changes associated with cocaine self-administration; (2) to determine the temporal course of adaptations in dopamine and opioid systems that may underlie these changes in functional activity as they develop over time; and (3) to examine the long term effects of novel tropane analogs synthesized in this Center that have been hypothesized as potential medications for cocaine addiction. It is hoped that this approach will provide important insights into the progressive changes that accompany cocaine abuse and provide a basis for developing pharmacological therapies treatments for addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
3P50DA006634-09S1
Application #
6332494
Study Section
Project Start
2000-01-01
Project End
2000-11-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
9
Fiscal Year
2000
Total Cost
$191,175
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Siciliano, Cody A; Saha, Kaustuv; Calipari, Erin S et al. (2018) Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation. J Neurosci 38:484-497
Ilyasov, Alexander A; Milligan, Carolanne E; Pharr, Emily P et al. (2018) The Endocannabinoid System and Oligodendrocytes in Health and Disease. Front Neurosci 12:733
Ding, Huiping; Kiguchi, Norikazu; Yasuda, Dennis et al. (2018) A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med 10:
Chen, R; McIntosh, S; Hemby, S E et al. (2018) High and low doses of cocaine intake are differentially regulated by dopamine D2 receptors in the ventral tegmental area and the nucleus accumbens. Neurosci Lett 671:133-139
John, William S; Martin, Thomas J; Solingapuram Sai, Kiran Kumar et al. (2018) Chronic ?9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability. J Pharmacol Exp Ther 364:300-310
Deadwyler, Sam A; Hampson, Robert E; Song, Dong et al. (2017) A cognitive prosthesis for memory facilitation by closed-loop functional ensemble stimulation of hippocampal neurons in primate brain. Exp Neurol 287:452-460
John, William S; Nader, Michael A (2017) Effects of ethanol on cocaine self-administration in monkeys responding under a second-order schedule of reinforcement. Drug Alcohol Depend 170:112-119
Blume, Lawrence C; Patten, Theresa; Eldeeb, Khalil et al. (2017) Cannabinoid Receptor Interacting Protein 1a Competition with ?-Arrestin for CB1 Receptor Binding Sites. Mol Pharmacol 91:75-86
Wesley, Michael J; Lile, Joshua A; Fillmore, Mark T et al. (2017) Neurophysiological capacity in a working memory task differentiates dependent from nondependent heavy drinkers and controls. Drug Alcohol Depend 175:24-35
John, William S; Martin, Thomas J; Nader, Michael A (2017) Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys. Neuropsychopharmacology 42:1522-1530

Showing the most recent 10 out of 310 publications